Skip to main content
. 2022 Mar 27;14(3):612–622. doi: 10.4254/wjh.v14.i3.612

Table 1.

Demographic, lifestyle and general health comorbidities of participants according to the presence of nonalcoholic fatty liver disease


All (n = 589)
Non-NAFLD (n = 354)
NAFLD (n = 235)
P value
Age, mean ± SD 59.97 ± 6.97 59.99 ± 7.40 59.94 ± 6.29 0.3959
Male, % 254 (43.12%) 131 (37.01%) 123 (52.34%) 0.0002
White, % 564 (95.76%) 340 (96.05%) 224 (95.32%) 0.6686
Smoking status, %
Current 70 (11.90%) 47 (13.31%) 23 (9.79%) 0.1958
Former 239 (40.65%) 141 (39.94%) 98 (41.70%) 0.6706
Non-smoker 279 (47.45%) 165 (46.74%) 114 (48.51%) 0.674
Regular exercise, %
Physically Inactive 171 (29.03%) 85 (24.01%) 86 (36.60%) 0.001
Moderate physical activity 230 (39.05%) 139 (39.27%) 91 (38.72%) 0.8949
Ideal physical activity 188 (31.92%) 130 (36.72%) 58 (24.68%) 0.0021
Obesity, % BMI
Lean 270 (45.84%) 255 (72.03%) 15 (6.38%) < 0.0001
Overweight 234 (39.73%) 99 (27.97%) 135 (57.45%) < 0.0001
Obese 85 (14.43%) 0 (0.00%) 85 (36.17%) < 0.0001
History of CVD, % 40 (6.79%) 23 (6.50%) 17 (7.23%) 0.7278
History of arthritis, % 68 (11.54%) 39 (11.02%) 29 (12.34%) 0.6226
History of cancer (any), % 97 (16.47%) 48 (13.56%) 49 (20.85%) 0.0195
Insulin resistance, % 157 (26.66%) 48 (13.56%) 109 (46.38%) < 0.0001
Hypertension, % 117 (19.86%) 66 (18.64%) 51 (21.70%) 0.3623
Hyperlipidemia, % 446 (75.72%) 245 (69.21%) 201 (85.53%) < 0.0001
Diabetes, % 74 (12.56%) 19 (5.37%) 55 (23.40%) < 0.0001
Metabolic syndrome1, % 125 (21.26%) 23 (6.52%) 102 (43.40%) < 0.0001
BDI, mean ± SD 4.00 ± 3.71 3.67 ± 3.62 4.49 ± 3.80 0.0041

CVD: Cardiovascular disease; NAFLD: Nonalcoholic fatty liver disease; SD: Standard deviation. NCEP ATP III (2005 revision).

1

P value by nonparametric Kruskal-Wallis Test for continuous variables, chi-square test for categorical variable, Data are presented as the mean ± SD for numerical variables and count (%) for categorical variables.